Navigation Links
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
Date:6/29/2010

clusive licensee of approximately 1,600 issued patents worldwide.  Additional information about Isis is available at www.isispharm.com.

This press release includes forward-looking statements regarding Isis' discovery and development of drugs for metabolic diseases, including the development, activity, therapeutic potential and safety of ISIS 113715 and ISIS-GCGRRx in the treatment of type 2 diabetes.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such products.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2009 and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company.

<
'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
2. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
3. DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call
4. LightLab Highlights OCT Market Leadership at the Society for Cardiovascular Angiography and Interventions
5. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
6. Bionovo Announces 2009 Highlights and Year-End Financial Results
7. Siemens Highlights Its Commitment to Excellence in Cardiology at ACC 2010
8. New Publication Highlights 2-Year Durability and Effectiveness of Macroplastique(R)
9. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
10. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
11. Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Capnia, Inc. (NASDAQ: ... diagnostics based on its proprietary Sensalyze™ Technology Platform ... financial results for the third quarter and nine ... the completion of our initial public offering (IPO), ... recently initiated CoSense® commercial launch," said Anish Bhatnagar, ...
(Date:12/19/2014)... 18, 2014 Baptist Health Lexington is the first ... receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status ... Atrial fibrillation is the most common cardiac arrhythmia and has ... can lead to stroke and possible death. More than 5 ... have atrial fibrillation and the numbers are rapidly increasing as ...
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
Breaking Medicine Technology:Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
(Date:12/19/2014)... December 20, 2014 These vanadium reserves ... other nations. Around 151,000 tons of vanadium were produced ... global vanadium usage increased at 6.7% AAGR during the ... and iron industry, being the largest consumer, accounted for ... followed by titanium-vanadium alloy and the chemical industry. , ...
(Date:12/19/2014)... News) -- The intestinal bacteria that cause inflammatory bowel ... be inherited, researchers report. The findings, published recently ... in efforts to prevent the disease and treat the ... authors added. "The intestinal bacteria, or ,gut microbiome, ... a big impact on your health for the rest ...
(Date:12/19/2014)... (HealthDay News) -- The cost of cancer treatment can ... study finds. Researchers examined data from 1,000 people ... colorectal or lung cancer. Of those patients, almost 900 ... than 100 had advanced cancer. Nearly half of ... medical bills, which was linked with a poorer health-related ...
(Date:12/19/2014)... Kan. (PRWEB) December 19, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Estes Park Medical Center in Estes Park, Colo. The ... E. Smith has recently placed more than 900 healthcare ... (EPMC) is a 25-bed, not-for-profit critical access hospital and ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Pain Free ... is excited to announce a new Superior magnetic ... magnets. These are the strongest neodymium magnets for the ... Free Living developed the Superior Magnetics brand for the ... Free Living performs magnetic therapy using Superior Magnetic Jewelry ...
Breaking Medicine News(10 mins):Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Estes Park Medical Center Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2
... -- If you are one of the many people who ... steps can help reduce your stress on Thanksgiving. Mary ... at Binghamton University, State University of New York, offers the ... of time and have a list ready for what you ...
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) -- ... has spread to the lymph nodes could prevent many unnecessary ... is usually done via a major operation called a thoracotomy. ... operation can remove the cancer. However, if the cancer has ...
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) -- ... almost 44 percent in those at highest risk for contracting the ... study finds. The reduction in risk climbed to nearly 73 ... percent of the time, the researchers added. Truvada is already ...
... Reinberg HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay ... of the year, many Americans will soon be subjected to ... rising tide of concerns and complaints in recent weeks over ... machines is too low to pose any serious health threat. ...
... (Nov. 23, 2010) Breast cancer stem cells (CSCs), the aggressive ... which promote metastasis, are stimulated by estrogen via a pathway ... were able to halt the expansion of breast CSCs, a ... done in mice, is published in the Proceedings of ...
... -- Ferrography, a practice used by the American and ... extracts tiny iron particles from lubricants such as oil ... a system requires preventative maintenance can be the key ... University scientists are exploring a modification of this technique ...
Cached Medicine News:Health News:Less Invasive Lung Cancer Staging Looks Promising 2Health News:Less Invasive Lung Cancer Staging Looks Promising 3Health News:Daily Pill Lowers Odds for Infection With HIV 2Health News:Daily Pill Lowers Odds for Infection With HIV 3Health News:Daily Pill Lowers Odds for Infection With HIV 4Health News:Airport Body Scanners Safe, Experts Say 2Health News:Airport Body Scanners Safe, Experts Say 3Health News:Discovery halts breast cancer stem cells 2Health News:Monitoring wear in helicopters -- and hips, knees and ankles, too 2Health News:Monitoring wear in helicopters -- and hips, knees and ankles, too 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: